A new F-box protein 7 gene mutation causing typical Parkinson's disease
Background Recessive mutations in the F‐box protein 7 gene (FBXO7; PARK15) have been identified as a cause of the parkinsonian‐pyramidal syndrome. Here, we report clinical and genetic findings in a Turkish family with novel FBXO7 mutations. Methods Whole exome and targeted Sanger sequencing were per...
Saved in:
Published in: | Movement disorders Vol. 30; no. 8; pp. 1130 - 1133 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Blackwell Publishing Ltd
01-07-2015
Wiley Subscription Services, Inc Wiley |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Recessive mutations in the F‐box protein 7 gene (FBXO7; PARK15) have been identified as a cause of the parkinsonian‐pyramidal syndrome. Here, we report clinical and genetic findings in a Turkish family with novel FBXO7 mutations.
Methods
Whole exome and targeted Sanger sequencing were performed for genetic analysis in a family with two members affected by Parkinson's disease (PD). All family members underwent detailed clinical, mental, and neurological examination.
Results
The new p.L34R (c.101 T>G) FBXO7 mutation was detected in a homozygous state in two Turkish sibs with typical levodopa‐responsive PD.
Conclusion
This is the first time a FBXO7 mutation has been identified that causes a phenotype compatible with typical idiopathic PD and presents with some of its common nonmotor features, such as rapid eye movement sleep behavior disorder, depression, and anxiety. © 2015 International Parkinson and Movement Disorder Society |
---|---|
Bibliography: | ark:/67375/WNG-2R3K78V0-G Eranet Neuron - No. (R08200DS) istex:9E4F65C7C39B2760767CD40167FC1492D6419EAE ArticleID:MDS26266 France-Parkinson Association and the French program "Investissements d'avenir" - No. (ANR-10-IAIHU-06) Full financial disclosures and author roles may be found in the online version of this article. Nothing to report. This work was funded by Eranet Neuron (R08200DS) France‐Parkinson Association and the French program “Investissements d'avenir” funding (ANR‐10‐IAIHU‐06). Relevant conflicts of interest/financial disclosures Funding agencies ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0885-3185 1531-8257 |
DOI: | 10.1002/mds.26266 |